Diatech Pharmacogenetics Expands Collaboration with Merck to Enhance Patient Access to Personalized Medicine in the Middle East and Africa

Diatech Pharmacogenetics (Jesi, Italy) announced an expansion of its collaboration with Merck Serono Middle East Ltd., affiliates of Merck KGaA (“Merck”). The collaboration aims to improve patient access to RAS biomarker testing in the Middle East and Africa (MEA) regions. Colorectal cancer is the third most common cancer worldwide, accounting for approximately 10% of all […]

logo Diatech Pharmacogenetics

Subscribe to Our Newsletter

You are leaving the U.S. & Canada Research Use Only (RUO) area.

The content you are about to access is intended for other markets and may include products or information not available in the U.S. or Canada.

logo Diatech Pharmacogenetics
Select Your Region

Please select your region to access the content that is most relevant to your location and applicable regulations.